Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
Latest Information Update: 09 May 2024
At a glance
- Drugs Pimonidazole (Primary)
- Indications Malignant melanoma; Skin cancer; Uveal melanoma
- Focus Diagnostic use
- 06 May 2024 Planned End Date changed from 1 Mar 2025 to 1 Mar 2027.
- 06 May 2024 Planned primary completion date changed from 1 Mar 2025 to 1 Mar 2027.
- 13 Apr 2023 Planned End Date changed from 1 Mar 2024 to 1 Mar 2025.